Home › Prostate Cancer › Connecticut
Prostate Cancer clinical trials in Connecticut
27 studies for Prostate Cancer are looking for participants at sites in Connecticut.
Cities in Connecticut
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Yale Cancer Center, New Haven
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Oct 2, 2026 · NCT04585750Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Stamford Hospital/Bennett Cancer Center, Stamford
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06632977A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Yale Cancer Center, New Haven
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06172478Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Yale University, New Haven
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Sep 25, 2026 · NCT06800313A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Yale-New Haven Hospital-Yale Cancer Center ( Site 0064), New Haven
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06136650Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Hartford Hospital, Hartford
RecruitingPhase 2/3
Ages 18 to 100 · Men · Updated Sep 22, 2026 · NCT06780670A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Hartford HealthCare Cancer Institute at Hartford Hospital, Hartford
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 22, 2026 · NCT07213674A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
- GSK Investigational Site, New Haven
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Sep 18, 2026 · NCT06990880High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT05011383A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Yale-New Haven Hospital-Yale Cancer Center ( Site 0050), New Haven
- Veterans Affairs Connecticut Healthcare System ( Site 0062), West Haven
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT06925737The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
- Yale Cancer Center, New Haven
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 14, 2026 · NCT06111781A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
- Yale Cancer Center, New Haven
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 8, 2026 · NCT05800665A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground Truth
- Wren Laboratories, Branford
RecruitingObservational study
Ages 45 to 80 · Men · Updated Aug 21, 2026 · NCT07454603Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Yale New Haven Hospital, New Haven
RecruitingPhase 1
Ages 18 and older · Men · Updated Aug 21, 2026 · NCT04221542A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- New Haven Hospital - Yale Cancer Center, New Haven
RecruitingPhase 2
Ages 18 and older · Men · Updated Aug 17, 2026 · NCT06842498FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Yale University School of Medicine, New Haven
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05919264Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Yale New Haven Hospital, New Haven
RecruitingPhase 1
Ages 18 to 100 · Men · Updated Aug 13, 2026 · NCT05519449A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
- Hartford Healthcare Alliance (Data collection only), Hartford
RecruitingPhase 2
Ages 18 and older · Men · Updated Jul 30, 2026 · NCT05751434Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven
RecruitingPhase 3
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06592924Integrated Cancer Repository for Cancer Research
- Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
- Yale University (Data Collection Only), New Haven
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Jun 25, 2026 · NCT06457919Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Hartford Hospital, Hartford
RecruitingPhase 4
Ages 18 to 100 · Men · Updated Jun 4, 2026 · NCT05803941International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Yale University, New Haven
RecruitingObservational study
Ages 21 and older · Men · Updated May 22, 2026 · NCT03151629A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Yale University, Yale Cancer Center, New Haven
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 27, 2026 · NCT06395519Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
- Smilow Cancer Hospital-Derby Care Center, Derby
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury
- and 11 more
RecruitingPhase 2
Ages 18 and older · Men · Updated Jan 29, 2026 · NCT05806515SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Hartford
- Massive Bio SYNERGY-AI site, Norwalk
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Smilow Cancer Hospital Care Center - Guilford, Guilford
- Yale University, New Haven
- Stamford Hospital/Bennett Cancer Center, Stamford
- and 3 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 11, 2025 · NCT03678025From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.